ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) shares were up 9.3% during mid-day trading on Friday . The stock traded as high as $0.45 and last traded at $0.45. Approximately 285,512 shares traded hands during mid-day trading, an increase of 1,305% from the average daily volume of 20,327 shares. The stock had previously closed at $0.41.
ImmunoPrecise Antibodies Trading Up 15.5 %
The company’s fifty day simple moving average is $0.42 and its 200 day simple moving average is $0.65.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Recommended Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Why is the Ex-Dividend Date Significant to Investors?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Use the MarketBeat Stock Screener
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- What Do S&P 500 Stocks Tell Investors About the Market?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
